The present invention provides forms of curcumin and the pharmaceutical compositions thereof. The forms of curcumin disclosed herein are curcumin polymorph Form III, curcumin-2-aminobenzimidazole co-crystal, and curcumin-L-lysine co-crystal. Further, the invention provides methods inhibiting cancer cells and HSV-1 using these curcumin novel solid forms.
申请公布号
WO2012138907(A2)
申请公布日期
2012.10.11
申请号
WO2012US32396
申请日期
2012.04.05
申请人
TRANSLATIONAL GENOMICS RESEARCH INSTITUTE;VAN ANDEL RESEARCH INSTITUTE;GATELY, STEPHEN T.;TRIEZENBERG, STEVEN J.